Formycon AG
XETRA:FYB
Formycon AG
Operating Income
Formycon AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Formycon AG
XETRA:FYB
|
Operating Income
-€369k
|
CAGR 3-Years
62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Operating Income
€908m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Operating Income
-€440.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
Operating Income
-€269.7m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Operating Income
-€101.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Operating Income
€196.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
102%
|
CAGR 10-Years
14%
|
See Also
What is Formycon AG's Operating Income?
Operating Income
-369k
EUR
Based on the financial report for Dec 31, 2023, Formycon AG's Operating Income amounts to -369k EUR.
What is Formycon AG's Operating Income growth rate?
Operating Income CAGR 3Y
62%
Over the last year, the Operating Income growth was 98%. The average annual Operating Income growth rates for Formycon AG have been 62% over the past three years .